Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Raw Materials (2018 - 2022)

AVITA Medical (RCEL) has disclosed Raw Materials for 1 consecutive years, with $1.1 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Raw Materials changed N/A year-over-year to $1.1 million, compared with a TTM value of $1.1 million through Dec 2022, changed N/A, and an annual FY2022 reading of $1.1 million, changed N/A over the prior year.
  • Raw Materials was $1.1 million for Q4 2022 at AVITA Medical.
  • Across five years, Raw Materials topped out at $1.1 million in Q4 2022 and bottomed at $1.1 million in Q4 2022.